The Clinical and Molecular Epidemiology of Streptococcus Agalactiae Colonisation on the Kenyan Coast

The Clinical and Molecular Epidemiology of Streptococcus Agalactiae (Group B Streptococcus)Maternal Colonisation and Association With Adverse Perinatal Outcomes

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01757041

Acronym

GBS

Enrollment

7967

Registered

2012-12-28

Start date

2011-09-30

Completion date

2013-10-31

Last updated

2014-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Streptococcus Agalactiae (Streptococcus Group B)

Keywords

Streptococcus agalactiae, Maternal, Newborn, Africa

Brief summary

Sub-Saharan Africa (sSA) has the highest regional rates of perinatal mortality worldwide. Group B Streptococcus (GBS) has been identified as a leading cause of early onset neonatal sepsis (EOS, in \<7 days of life) in sSA. In other regions, maternal carriage is associated with early onset neonatal sepsis, but in addition, other adverse perinatal outcomes (stillbirths, early neonatal death, low birth weight and prematurity). Robust data on maternal GBS carriage in sSA and its burden on adverse perinatal outcomes are lacking, with important consequences for public health interventions. Through investigation of maternal carriage and perinatal outcomes at three different sites: rural, semi-rural and urban, this study will provide a comprehensive description of the burden of GBS in coastal Kenya, informing public health policy and driving forward interventions. Risk factors for maternal colonisation and invasive neonatal disease will be assessed, including through retrospective immunological investigation of cord blood in neonates subsequently identified as having invasive GBS disease or other adverse perinatal outcomes, compared to those without. GBS isolates from maternal colonisation will be typed (sero-typing and molecular analysis), and these isolates will be compared to existing archived neonatal isolates from investigation of neonatal sepsis in KDH (Kilifi District Hospital). This is important so that we know the prevalent sub-types causing neonatal disease in Kenya, those which are carried by mothers, and therefore whether maternal GBS carriage correlates with a high risk of perinatal disease. GBS vaccines in development are type-specific and this will inform their use in sSA. Stillbirths will also be investigated, in individual cases, through additional detailed microbiological and other laboratory investigations to make an assessment of the contribution of GBS to stillbirths in Kenya.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

* Admitted for delivery

Exclusion criteria

* Consent refusal

Design outcomes

Primary

Measure	Time frame	Description
Maternal recto-vaginal GBS colonisation	Single time point (at delivery)	Prevalence of GBS recto-vaginal carriage in pregnant mothers in rural, semi-rural and urban sites.

Secondary

Measure	Time frame	Description
Stillbirths	Single time point (at delivery)	Association of stillbirth with Group B Streptococcus
Neonatal GBS Colonisation	Within 4h of delivery	Prevalence of neonatal GBS colonization
Preterm birth	Single time point (at delivery)	Determine association between GBS and preterm birth
Low birth weight	Single time point (at delivery)	Association of GBS with low birth weight babies

Countries

Kenya

Outcome results